Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

In vitro bioassays are better than traditional methods for measuring androgen activity but aren't ready for routine use yet.

Future drugs targeting specific hair growth steps could improve treatments for hair growth issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

Flutamide effectively reduces hair growth in women with hirsutism and improves acne and seborrhea without side effects.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.